- Home
- INVA vs STAA Comparison
INVA vs STAA Comparison
Compare INVA & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INVA
- STAA
- Stock Information
- Founded
- INVA 1996
- STAA 1982
- Country
- INVA United States
- STAA United States
- Employees
- INVA N/A
- STAA N/A
- Industry
- INVA Biotechnology: Pharmaceutical Preparations
- STAA Ophthalmic Goods
- Sector
- INVA Health Care
- STAA Health Care
- Exchange
- INVA Nasdaq
- STAA Nasdaq
- Market Cap
- INVA 1.3B
- STAA 1.4B
- IPO Year
- INVA 2004
- STAA N/A
- Fundamental
- Price
- INVA $19.89
- STAA $27.16
- Analyst Decision
- INVA Strong Buy
- STAA Hold
- Analyst Count
- INVA 4
- STAA 8
- Target Price
- INVA $40.25
- STAA $22.50
- AVG Volume (30 Days)
- INVA 672.9K
- STAA 667.8K
- Earning Date
- INVA 11-05-2025
- STAA 10-29-2025
- Dividend Yield
- INVA N/A
- STAA N/A
- EPS Growth
- INVA N/A
- STAA N/A
- EPS
- INVA 0.53
- STAA N/A
- Revenue
- INVA $370,229,000.00
- STAA $224,449,000.00
- Revenue This Year
- INVA $8.17
- STAA N/A
- Revenue Next Year
- INVA $12.06
- STAA $27.24
- P/E Ratio
- INVA $37.06
- STAA N/A
- Revenue Growth
- INVA 12.02
- STAA N/A
- 52 Week Low
- INVA $16.67
- STAA $13.50
- 52 Week High
- INVA $22.00
- STAA $38.60
- Technical
- Relative Strength Index (RSI)
- INVA 50.33
- STAA 56.68
- Support Level
- INVA $19.24
- STAA $26.98
- Resistance Level
- INVA $19.74
- STAA $28.13
- Average True Range (ATR)
- INVA 0.48
- STAA 0.47
- MACD
- INVA -0.11
- STAA -0.35
- Stochastic Oscillator
- INVA 38.81
- STAA 12.86
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.